Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
The current Natera(NTRA) stock price is $319.09, with a market capitalization of 46.29B. The stock trades at a price-to-earnings (P/E) ratio of -281.72.
On 2026-11-13, Natera(NTRA) stock traded between a low of $312.10 and a high of $326.50. Shares are currently priced at $319.09, which is +2.2% above the low and -2.3% below the high.
Natera(NTRA) shares are trading with a volume of 1.68M, against a daily average of 2.85M.
During the past year, Natera(NTRA) stock moved between $181.00 at its lowest and $437.41 at its peak.
During the past year, Natera(NTRA) stock moved between $181.00 at its lowest and $437.41 at its peak.
NTRA News
On CNBC’s “Halftime Report Final Trades,” Bill Baruch, founder and CIO of both Blue Line Capital and Blue Creek Capital Management, picked Micron Technology, In...
Natera (NasdaqGS:NTRA) and Incyte announced a clinical collaboration using Signatera in a Phase II colorectal cancer immunotherapy trial. The study will use Si...
Natera (NTRA) is back in focus after a busy early November, with Q3 2026 results, higher full year revenue guidance, fresh Signatera cancer data and a CEO trans...
Analyst ratings
88%
of 25 ratingsMore NTRA News
Natera, Inc. (NTRA Quick QuoteNTRA - Free Report) used its third-quarter 2026 earnings call to outline an ambitious revenue target, highlight accelerating...
Natera reported Q3 2026 revenue of US$793.98 million and a net loss of US$59.91 million, raised full year revenue guidance above US$3b, and at the same time ann...
has seen its stock price race ahead in recent years, while fresh clinical data and product wins keep reshaping expectations for its business. With the share pri...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.